LON:AREC Arecor Therapeutics (AREC) Share Price, News & Analysis GBX 81.50 +3.00 (+3.82%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range 75▼ 8250-Day Range 78▼ 12052-Week Range 78▼ 199Volume59,515 shsAverage Volume14,571 shsMarket Capitalization£30.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Arecor Therapeutics alerts: Email Address Ad Deal MakerThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.Learn more about this much-needed advancement and investment opportunity here. About Arecor Therapeutics Stock (LON:AREC)Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It also offers Ogluo, a ready-to-use glucagon auto-injector pen that is used to treat hypoglycaemia in patients with diabetes; and specialty hospital care products. In addition, the company is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. It has a research collaboration with TRx Biosciences Limited for the formulation development of an oral glucagon-like peptide-1 (GLP-1) receptor agonist product. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.Read More AREC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AREC Stock News HeadlinesMay 20, 2024 | finance.yahoo.comAt278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 DiabetesMay 9, 2024 | lse.co.ukArecor Therapeutics collaborates with Medtronic on novel insulinSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…May 9, 2024 | finanznachrichten.deArecor Therapeutics plc: Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump deliveryApril 23, 2024 | lse.co.ukArecor chief financial officer to leave in July after five yearsApril 18, 2024 | morningstar.comArecor Therapeutics PLC Ordinary Shares ARECApril 2, 2024 | lse.co.ukStrip Tinning shares up as hails "largest ever" glazing orderMarch 14, 2024 | finance.yahoo.comArecor Therapeutics announces collaboration on oral GLP-1 drug for diabetes and obesity treatmentSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…March 12, 2024 | lse.co.ukArecor to develop "holy grail" diabetes treatment with partner TRxMarch 12, 2024 | finance.yahoo.comARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITYFebruary 16, 2024 | finance.yahoo.comArecor Therapeutics plc (AREC.L)February 1, 2024 | lse.co.ukArecor Therapeutics hails Arestat as 2023 performance "strong"January 20, 2024 | morningstar.comArecor Therapeutics PLC Ordinary SharesJanuary 18, 2024 | lse.co.ukTRADING UPDATES: Patent boosts for DG Innovate and Arecor TherapeuticsDecember 4, 2023 | lse.co.ukArecor inks co-development deal with global medical companyNovember 17, 2023 | finance.yahoo.comArecor Therapeutics takes major step with first commercial sale of AT220November 2, 2023 | lse.co.ukTRADING UPDATES: Troy Income suspends buyback of sharesSee More Headlines Receive AREC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryCoal Current SymbolLON:AREC CUSIPN/A CIKN/A Webwww.americanresourcescorp.com Phone44 1223 426 060FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-8,550,000.00 Net Margins-187.05% Pretax MarginN/A Return on Equity-63.41% Return on Assets-30.88% Debt Debt-to-Equity Ratio3.55 Current Ratio2.17 Quick Ratio6.24 Sales & Book Value Annual Sales£4.57 million Price / Sales6.73 Cash FlowGBX 16.07 per share Price / Cash Flow5.07 Book ValueGBX 31 per share Price / Book2.63Miscellaneous Outstanding Shares37,760,000Free FloatN/AMarket Cap£30.77 million OptionableNot Optionable Beta-0.17 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesDr. Sarah Jennifer Howell Ph.D. (Age 49)CEO & Director Comp: $421kMs. Susan Day Lowther FCMA (Age 64)CFO, Company Secretary & Director Comp: $306kDr. Jan Jezek Ph.D.Chief Scientific OfficerMr. David GerringSenior Vice President of DevelopmentDr. Manjit Rahelu Ph.D.Chief Business OfficerKey CompetitorsFutura MedicalLON:FUMTiziana Life SciencesLON:TILSVerseonLON:VSNMereo BioPharma Group plc (MPH.L)LON:MPHOpen OrphanLON:ORPHView All Competitors AREC Stock Analysis - Frequently Asked Questions How have AREC shares performed this year? Arecor Therapeutics' stock was trading at GBX 182.50 at the start of the year. Since then, AREC stock has decreased by 55.3% and is now trading at GBX 81.50. View the best growth stocks for 2024 here. How do I buy shares of Arecor Therapeutics? Shares of AREC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:AREC) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AREC Stock Alerts